Chronic angiotensin-(1-7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-β/Smad signaling pathway in rabbits

Biochemical and Biophysical Research Communications

Volumn 389, Issue 1, 2009, Pages 138-144

  Zeng, Wutao ^a   Chen, Weiyan ^a   Leng, Xiuyu ^a   He, Jian gui ^a   Ma, Hong ^a  

^a First Affiliated Hospital   (China)

Author keywords

Angiotensin; Transforming growth factor beta; Vascular remodeling

Indexed keywords

ANGIOTENSIN[1-7]; COLLAGEN TYPE 1; COLLAGEN TYPE 3; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD2 PROTEIN; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA INJURY; ARTERY DIAMETER; ARTICLE; COLLAGEN SYNTHESIS; CONTROL GROUP; CONTROLLED STUDY; DESCENDING AORTA SURGERY; DOWN REGULATION; ENZYME INHIBITION; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RABBIT; RESTENOSIS; SIGNAL TRANSDUCTION;

ANGIOPLASTY; ANIMALS; AORTA, ABDOMINAL; BLOOD PRESSURE; COLLAGEN TYPE I; COLLAGEN TYPE III; HEART RATE; RABBITS; RATS; REGENERATION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUNICA INTIMA;

ANIMALIA; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 70349095254     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.112     Document Type: Article

References (24)

1. van Lankeren W., Gussenhoven E.J., Honkoop J., Stijnen T., van Overhagen H., Wittens C.H., Kranendonk S.E., van Sambeek M.R., and van der Lugt A. Plaque area increase and vascular remodeling contribute to lumen area change after percutaneous transluminal angioplasty of the femoropopliteal artery: an intravascular ultrasound study. J. Vasc. Surg. 29 (1999) 430-441
2. P. Chan, Developments in Restenosis, 2002, pp. 145-149.
3. Langeveld B., Roks A.J., Tio R.A., Voors A.A., Zijlstra F., and Van Gilst W.H. Renin-angiotensin system intervention to prevent in-stent restenosis: an unclosed chapter. J. Cardiovasc. Pharmacol. 45 (2005) 88-98
4. Yoshikawa M., Nakamura K., Nagase S., Sakuragi S., Kusano K.F., Matsubara H., and Ohe T. Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis. J. Cardiovasc. Pharmacol. 53 (2009) 179-186
5. Ribichini F., Wijns W., Ferrero V., Matullo G., Camilla T., Feola M., Guarrera S., Vado A., Piazza A., and Uslenghi E. Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting. Am. J. Cardiol. 91 (2003) 154-158
6. Santos R.A., Frezard F., and Ferreira A.J. Angiotensin-(1-7): blood, heart, and blood vessels. Curr. Med. Chem. Cardiovasc. Hematol. Agents 3 (2005) 383-391
7. Langeveld B., van Gilst W.H., Tio R.A., Zijlstra F., and Roks A.J. Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat. Hypertension 45 (2005) 138-141
8. Strawn W.B., Ferrario C.M., and Tallant E.A. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension 33 (1999) 207-211
9. Iwata M., Cowling R.T., Gurantz D., Moore C., Zhang S., Yuan J.X., and Greenberg B.H. Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H2356-H2363
10. Grobe J.L., Mecca A.P., Lingis M., Shenoy V., Bolton T.A., Machado J.M., Speth R.C., Raizada M.K., and Katovich M.J. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H736-H742
11. Annes J.P., Munger J.S., and Rifkin D.B. Making sense of latent TGFbeta activation. J. Cell Sci. 116 (2003) 217-224
12. Nikol S., Isner J.M., Pickering J.G., Kearney M., Leclerc G., and Weir L. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J. Clin. Invest. 90 (1992) 1582-1592
13. Wolf Y.G., Rasmussen L.M., and Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J. Clin. Invest. 93 (1994) 1172-1178
14. Yamamoto K., Morishita R., Tomita N., Shimozato T., Nakagami H., Kikuchi A., Aoki M., Higaki J., Kaneda Y., and Ogihara T. Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease. Circulation 102 (2000) 1308-1314
15. Kingston P.A., Sinha S., David A., Castro M.G., Lowenstein P.R., and Heagerty A.M. Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition. Circulation 104 (2001) 2595-2601
16. Ruiz-Ortega M., Rodriguez-Vita J., Sanchez-Lopez E., Carvajal G., and Egido J. TGF-beta signaling in vascular fibrosis. Cardiovasc. Res. 74 (2007) 196-206
17. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 (2001) 1191-1194
18. Bujak M., and Frangogiannis N.G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 74 (2007) 184-195
19. Kalinina N., Agrotis A., Antropova Y., Ilyinskaya O., Smirnov V., Tararak E., and Bobik A. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1391-1396
20. Wang X.L., Liu S.X., and Wilcken D.E. Circulating transforming growth factor beta 1 and coronary artery disease. Cardiovasc. Res. 34 (1997) 404-410
21. Lutgens E., Gijbels M., Smook M., Heeringa P., Gotwals P., Koteliansky V.E., and Daemen M.J. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 975-982
22. Os I., Djurovic S., Seljeflot I., and Berg K. Transforming growth factor (TGF)-beta1 inversely related to vascular cell adhesion molecule-1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative cardioprotective role of TGF-beta1?. J. Intern. Med. 251 (2002) 223-227
23. Verrecchia F., Chu M.L., and Mauviel A. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J. Biol. Chem. 276 (2001) 17058-17062
24. Verrecchia F., and Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J. Invest. Dermatol. 118 (2002) 211-215